PRESS RELEASE published on 08/06/2024 at 21:07, 1 year 7 months ago Evotec provides guidance update Evotec SE refines guidance for fiscal year 2024, expecting moderate revenue growth, reduced R&D expenditures, and adjusted EBITDA; aims for sustainable profitable growth amid market challenges Adjusted EBITDA Revenue Growth Evotec SE Guidance Update R&D Expenditures
PRESS RELEASE published on 08/06/2024 at 21:04, 1 year 7 months ago EQS-Adhoc: Evotec SE provides guidance update Evotec SE refines guidance for fiscal year 2024, expecting revenue and EBITDA adjustments due to slower sales conversion and margin pressures, focusing on sustainable growth EBITDA Revenue Evotec SE Sustainable Growth Guidance Update
BRIEF published on 07/10/2024 at 07:35, 1 year 8 months ago Evotec and Pfizer Collaborate to Advance Drug Discovery in France Drug Discovery Metabolic Diseases Evotec Pfizer Infectious Diseases
PRESS RELEASE published on 07/10/2024 at 07:30, 1 year 8 months ago Evotec and Pfizer collaborate to advance drug discovery in France Evotec SE collaborates with Pfizer to focus on early discovery research for metabolic and infectious diseases in France. The multi-year agreement includes research support and potential milestones Drug Discovery Evotec SE France Pfizer Metabolic And Infectious Diseases
BRIEF published on 07/08/2024 at 14:05, 1 year 8 months ago Just – Evotec Biologics Expands Tech Partnership for Biosimilars with Sandoz Partnership Biosimilars Evotec Sandoz Biologics
PRESS RELEASE published on 07/08/2024 at 14:00, 1 year 8 months ago Just – Evotec Biologics expands tech partnership for biosimilars with Sandoz Evotec SE's biologics segment, Just - Evotec Biologics, expands partnership for biosimilars with Sandoz, securing long-term commercial supply. Collaboration aims for cost-efficient development Evotec SE Biosimilars Just - Evotec Biologics Sandoz Commercial Supply
BRIEF published on 06/25/2024 at 07:35, 1 year 9 months ago Just-Evotec Biologics Selected by U.S. DOD for Manufacturing Optimization Evotec SE Biologics Manufacturing U.S. Department Of Defense Monoclonal Antibodies Medical Countermeasures
PRESS RELEASE published on 06/25/2024 at 07:30, 1 year 9 months ago Just – Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program Just \/ Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program. Evotec SE subsidiary chosen for $39m accelerated mAb development project Evotec SE Just - Evotec Biologics U.S. Department Of Defense Manufacturing Optimization Program MAb Development
BRIEF published on 06/12/2024 at 07:35, 1 year 9 months ago Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb Collaboration Neuroscience Evotec Neurodegenerative Diseases Bristol Myers Squibb
PRESS RELEASE published on 06/12/2024 at 07:30, 1 year 9 months ago Evotec announces progress in neuroscience collaboration with Bristol Myers Squibb Evotec SE makes progress in neuroscience collaboration with Bristol Myers Squibb, receiving a US$20m research payment. The partnership focuses on developing treatments for neurodegenerative diseases Evotec SE Neurodegenerative Diseases Bristol Myers Squibb Neuroscience Collaboration Research Payment
Published on 03/29/2026 at 12:15, 2 hours 21 minutes ago China Xlx Announces 2025 Annual Results Deepening Efforts in Reducing Costs, Enhancing Efficiency, Strengthening Competitiveness Through Differentiation and Driving Marketing Transformation
Published on 03/28/2026 at 01:00, 1 day 12 hours ago Battery X Metals Announces Confidential Submission of Amended Draft Registration Statement with the U.S. Securities and Exchange Commission in Connection with Proposed U.S. National Securities Exchange Initial Public Offering
Published on 03/28/2026 at 00:55, 1 day 12 hours ago Notification of Relevant Change to Significant Shareholder
Published on 03/27/2026 at 22:45, 1 day 14 hours ago Caledonia Mining Corporation Plc - Notification of Relevant Change to Significant Shareholder
Published on 03/28/2026 at 10:05, 1 day 4 hours ago Hisense Advances a Quiet Green Revolution in Home Entertainment
Published on 03/28/2026 at 08:56, 1 day 5 hours ago Turkiye Garanti Bankasi A.S.: Sale of Garanti Bank S.A. and our public disclosure dated 10.03.2026
Published on 03/28/2026 at 01:42, 1 day 11 hours ago EQS-Adhoc: Raiffeisen Bank International AG: Agreement on the acquisition of Garanti BBVA Group Romania
Published on 03/27/2026 at 21:58, 1 day 15 hours ago Kaufman & Broad SA: Availability of the Universal Registration Document 2025
Published on 03/27/2026 at 20:08, 1 day 17 hours ago EQS-Adhoc: CECONOMY AG: Information on the ongoing public takeover process – uncertainty regarding FDI clearance in Austria
Published on 03/27/2026 at 18:52, 1 day 18 hours ago Crédit Agricole CIB announces the publication of its 2025 Universal Registration Document
Published on 03/27/2026 at 18:40, 1 day 18 hours ago 2026 share capital increase reserved for members of the Saint-Gobain Group employee savings plan
Published on 03/27/2026 at 17:53, 1 day 19 hours ago Publication of Carrefour's 2025 Universal Registration Document
Published on 03/27/2026 at 17:45, 1 day 19 hours ago PUBLICATION OF THE UNIVERSAL REGISTRATION DOCUMENT FISCAL YEAR 2025
